Elsevier

Human Pathology

Volume 30, Issue 3, March 1999, Pages 288-294
Human Pathology

Original contribution
Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach

https://doi.org/10.1016/S0046-8177(99)90007-2Get rights and content

Abstract

The histological distinction between intestinal metaplasia involving the distal esophagus (Barrett's esophagus [BE]) and intestinal metaplasia of the stomach has important clinical implications and can be difficult even with the use of histochemical mucin stains. Cytokeratin (CK) 7 and 20 are cytoplasmic structural proteins that show restricted expression in normal and malignant epithelia of the gastrointestinal tract. The aim of this study was to determine the use of CK7 and 20 expression in the histological distinction of BE from gastric intestinal metaplasia. CK7 and 20 immunostaining was performed on randomly selected surgical resection (n = 31) and biopsy specimens (n = 34) from patients with long-segment BE and gastric resection specimens (n = 11) and gastric cardia biopsy specimens (n = 13) in patients with histological evidence of intestinal metaplasia. A unique pattern of immunoreactivity designated the Barrett's CK720 pattern showed superficial CK20 staining and strong CK7 staining of both superficial and deep glands in 29 of 31 (94%) esophageal resection specimens and 34 of 34 (100%) esophageal biopsy specimens form patients with long-segment BE. A Barrett's CK720 pattern was not observed in gastric cardia biopsy specimens (n = 13) or gastric resection specimens (n = 11) in patients with histological evidence of intestinal metaplasia. The sensitivity, specificity, and positive predictive value of a Barrett's CK720 pattern for a diagnosis of long-segment BE was 97%, 100%, and 100%, respectively. CK7 and 20 reactivity patterns can reliably identify the location of intestinal metaplasia in the esophagus and stomach using histological material from both routine endoscopic biopsy and surgical resection specimens.

References (32)

  • P Sharma et al.

    Dysplasia in short-segment Barrett's' esophagus: A prospective 3-year follow up

    Am J Gastroenterol

    (1997)
  • RE Petras et al.

    Barrett's' esophagus: A review of the pathologist's role in diagnosis and management

    Pathol Ann

    (1991)
  • R Moll

    Cytokeratins in the histological diagnosis of malignant tumors

    Int J Biol Markers

    (1994)
  • CC Van Niekerk et al.

    Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues

    J Pathol

    (1991)
  • R Moll et al.

    Cytokeratin 20 in human carcinomas: A new histodiagnostic marker detected by monoclonal antibodies

    Am J Pathol

    (1992)
  • NP Wang et al.

    Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas

    Appl Immunohistochem

    (1995)
  • Cited by (211)

    • Keratin intermediate filaments in the colon: guardians of epithelial homeostasis

      2020, International Journal of Biochemistry and Cell Biology
      Citation Excerpt :

      Of the different CRC types, well and moderately differentiated adenocarcinomas, mucinous adenocarcinoma and signet ring cell carcinoma most frequently exhibited a K7-negative and K20-positive phenotype (Bayrak et al., 2011; Yamagishi et al., 2013). The lack of K7 expression (Fig. 4) is no surprise, as K7 is not usually found in healthy intestinal epithelia and considered a marker of ductal differentiation (Ormsby et al., 1999). Nevertheless, focal K7 expression is sometimes found in normal colon mucosa, especially close to cancerous tissue (Gurzu and Jung, 2012).

    • Barrett's oesophagus diagnostic criteria: Endoscopy and histology

      2015, Best Practice and Research: Clinical Gastroenterology
    • Barrett esophagus: Diagnostic challenges

      2014, Seminars in Diagnostic Pathology
    View all citing articles on Scopus
    View full text